BofA raised the firm’s price target on Alignment Healthcare (ALHC) to $18.50 from $15.50 and keeps a Buy rating on the shares after the company had “a markedly stronger quarter than most of its peers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback